Spectrum and Characterisation of BRCA1 and BRCA2deleterious Mutations in High-Risk Czech Patients With Breast and/or Ovarian Cancer

BMC Cancer - United Kingdom
doi 10.1186/1471-2407-8-140
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Management of Breast Cancer Risk in Women With Ovarian Cancer and Deleterious BRCA1 or BRCA2 Mutations

Annals of Surgical Oncology
OncologySurgery
2017English

BRCA1 and BRCA2 Mutations in Danish Families With Hereditary Breast and/or Ovarian Cancer

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
2008English

Frequency of BRCA1 Mutations in B&H Breast and Ovarian Cancer Patients

Genetics & Applications
2018English

Oral Contraceptive Use and Ovarian Cancer Risk Among Carriers of BRCA1 or BRCA2 Mutations

British Journal of Cancer
Cancer ResearchOncology
2004English

Large BRCA1 and BRCA2 Genomic Rearrangements in Danish High Risk Breast-Ovarian Cancer Families

Breast Cancer Research and Treatment
Cancer ResearchOncology
2008English

BRCA1 and BRCA2 Mutations and Clinical Interpretation in 398 Ovarian Cancer Patients: Comparison With Breast Cancer Variants in a Similar Population

Human Genomics
Molecular MedicineDrug DiscoveryGeneticsMolecular Biology
2018English

Prevalence of BRCA1 and BRCA2 Mutations in Breast Cancer Patients From Brazil

Breast Cancer Research and Treatment
Cancer ResearchOncology
2006English

Novel Germline Mutations and Unclassified Variants of BRCA1 and BRCA2 Genes in Chinese Women With Familial Breast/Ovarian Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Founder BRCA1/2 Mutations Among Male Patients With Breast Cancer in Israel

American Journal of Human Genetics
Genetics
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy